BeOne Medicines
Melika Davis joined BeiGene in August 2019 as Vice President and Global Head, Clinical Operations. In this segment, she leads the overall strategy for the Global Clinical Operations organization and oversees the management and execution of all clinical trials at BeiGene. With a career dedicated to transforming clinical trials, Ms. Davis has built and grown successful global organizations that have brought 20 medical products to the market. Prior to joining BeiGene, she spent 15 years at Novartis leading its clinical monitoring operations group and served most recently as Senior Vice President and Global Head of Drug Development Quality. Previously, Ms. Davis worked at Schering Plough for 13 years in roles of increasing responsibilities in research and development. She received an M.S. in Molecular Biology and a B.S. from Texas Women’s University in Dallas and a License de Physiologie from the University of Sciences in Nice, France.
This person is not in any offices
BeOne Medicines
34 followers
BeOne Medicines is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of more than 11,000 colleagues spanning six continents, the Company is committed to radically improving access to medicines for far more patients who need them.